Scientific Reports (Aug 2022)

Changes in lumbar lordosis and predicted minimum 5-year surgical outcomes after short-segment transforaminal lumbar interbody fusion

  • Yasuchika Aoki,
  • Masahiro Inoue,
  • Hiroshi Takahashi,
  • Arata Nakajima,
  • Masato Sonobe,
  • Fumiaki Terajima,
  • Takayuki Nakajima,
  • Yusuke Sato,
  • Go Kubota,
  • Masashi Sato,
  • Satoshi Yoh,
  • Shuhei Ohyama,
  • Junya Saito,
  • Masaki Norimoto,
  • Yawara Eguchi,
  • Sumihisa Orita,
  • Kazuhide Inage,
  • Yasuhiro Shiga,
  • Seiji Ohtori,
  • Koichi Nakagawa

DOI
https://doi.org/10.1038/s41598-022-18679-7
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Although most patients who undergo transforaminal lumbar interbody fusion (TLIF) show favorable surgical results, some still have unfavorable results for various reasons. This study aimed to investigate the influence of differences in lumbar lordosis (LL) between the standing and supine positions (DiLL: supine LL–standing LL) on minimum 5-year surgical outcomes after short-segment TLIF. Ninety-one patients with lumbar degenerative disease who underwent short-segment TLIF (1–2 levels) were categorized based on preoperative differences in LL as DiLL (+) and DiLL (−). Comparison and correlation analyses were performed. The incidence of adjacent segment disease (ASD) by radiology (R-ASD) and symptomatic ASD (S-ASD), bony fusion rates, and pre- and postoperative clinical scores (visual analog scale [VAS]; Japanese Orthopaedic Association [JOA] score; Oswestry disability index (ODI); and Nakai’s score) were evaluated. Postoperatively, VAS for low back pain (LBP) in the sitting position, JOA scores for LBP, lower leg pain, intermittent claudication, ODI, and Nakai’s score were significantly worse in the DiLL (+) group than in the DiLL (−) group. DiLL values were significantly correlated with VAS for LBP, ODI, and Nakai’s score, postoperatively. Positive DiLL values were associated with poorer postoperative outcomes. DiLL is a simple and useful method for predicting mid-term outcomes after TLIF.